Penske Automotive Group Inc. (PAG) Financials Nov 14, 2014,
Penske Automotive Group Inc. (PAG) Financials Nov 14, 2014, 4:02 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Penske Automotive Group Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 9.52B 10.71B 11.56B 13.16B 14.71B
Cost of Goods Sold (COGS) incl. D&A 8B 9.06B 9.78B 11.2B 12.51B
COGS excluding D&A 7.94B 9.01B 9.73B 11.15B 12.45B
Depreciation & Amortization Expense 54.23M 48.88M 48.9M 54M 61.7M
Depreciation - - - 54M 61.7M
Amortization of Intangibles - - - - 0
Gross Income 1.53B 1.65B 1.78B 1.96B 2.2B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.32B 1.41B 1.48B 1.59B 1.76B
Research & Development - - 0 0 0
Other SG&A 1.32B 1.41B 1.48B 1.59B 1.76B
Other Operating Expense 0 0 0 0 0
Unusual Expense (10.43M) (1.63M) 0 17.75M 0
EBIT after Unusual Expense 10.43M 1.63M 0 (17.75M) 0
Non Operating Income/Expense 0 (8.64M) 0 0 0
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 13.81M 20.57M 25.45M 27.57M 30.7M
Interest Expense 103.91M 84.25M 75.25M 85.69M 91.5M
Gross Interest Expense 103.91M 84.25M 75.25M 113.19M 119.3M
Interest Capitalized 0 0 0 27.5M 27.8M
Pretax Income 129.43M 170.17M 248.39M 288.99M 375.4M
Income Tax 45.39M 57.91M 71.93M 94.33M 124.3M
Income Tax - Current Domestic (26.35M) 2.62M 19.81M (15.86M) 12.9M
Income Tax - Current Foreign 25.45M 27.58M 4.93M 26.89M 33.8M
Income Tax - Deferred Domestic 45.2M 26.81M 35.1M 81.92M 80.8M
Income Tax - Deferred Foreign 1.09M 904,000 12.09M 1.38M (3.2M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income 84.04M 112.26M 176.46M 194.66M 251.1M
Minority Interest Expense 459,000 1.07M 1.38M 1.63M 1.5M
Net Income 83.58M 111.19M 175.08M 193.03M 249.6M
Extraordinaries & Discontinued Operations (7.12M) (2.91M) 1.8M (7.49M) (5.4M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations (7.12M) (2.91M) 1.8M (7.49M) (5.4M)
Net Income After Extraordinaries 76.46M 108.28M 176.88M 185.54M 244.2M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 83.58M 111.19M 175.08M 193.03M 249.6M
EPS (Basic) 0.83 1.18 - 2.05 2.71
Basic Shares Outstanding 91.56M 92.02M - 90.32M 90.27M
EPS (Diluted) 0.83 1.18 - 2.05 2.70
Diluted Shares Outstanding 91.65M 92.09M - 90.34M 90.33M
EBITDA 263.33M 289.73M 347.09M 418.85M 497.9M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
Top 5 Most Recently Viewed Articles
Marvell Tech's Expected Earnings Release Marvell Tech (NASDAQ: MRVL) is set to announce its latest quarterly earnings in December. As investors await this critical financial moment, a brief review of what to expect can shed light on potential impacts and opportunities. Analysts' Earnings Projections Analysts forecast that Marvell Tech will achieve an earnings per share...
Continue Reading
Recent Share Transactions Overview Banijay Group N.V. (ISIN: NL0015000X07, Bloomberg: BNJ NA, Reuters: BNJ.AS) has reported on its recent share transactions, showcasing the buying and selling activities from the period of September 22 to September 26. Understanding Share Transactions During this timeframe, a mix of buying and selling occurred within the company’s...
Continue Reading
Voyageur Mineral Explorers Corp. Secures Massive Funding Voyageur Mineral Explorers Corp. (CSE: VOY) has recently made headlines by completing a significant brokered offering, raising $37.5 million. This financial boost comes at a crucial time for the Company as it seeks to expand its operations and investments in the mineral exploration sector. The offering was executed...
Continue Reading
Applied Materials Inc. Stock Performance Applied Materials Inc. (NASDAQ: AMAT) recently experienced a noticeable decline in its stock value as the company shared its financial results. After the market closure, the organization revealed its third-quarter earnings, leading to significant concern among investors. The stock's value tumbled, reflecting the market's reaction...
Continue Reading
Understanding the VFC Class Action Lawsuit Investors in V.F. Corporation, commonly known as VFC, should pay close attention to a pending class action lawsuit that could have significant implications. The law firm Faruqi & Faruqi, a reputable name in securities litigation, has stepped forward to represent affected investors. They are drawing attention to a critical...
Continue Reading